Updates

Playtech - Trading ahead of expectations

October 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Playtech had been in bid discussions since mid-October 2021 when Aristocrat first made a 680p cash bid - and during this time the market was starved of updates. But now, finally, Playtech’s H1 shows strong momentum with sales +73% to €792m and EBITDA +64% to €203.8m. The divisional breakdown is pretty intoxicating. Within B2C, the main business is Snaitech, which has maintained its number one position by brand across retail and online sports betting in Italy. In the half it grew sales 182% and adjusted EBITDA was €131.7m or +154%m, benefiting from retail reopening when gamblers made their way back to the shops. Its retail betting licences were extended until June 2024, at a cost of €23m, while its gaming machines rights were extend ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

AD Dynamics - Buys high spec simulator business

Concurrent Technologies

Playtech - Upgrades its 3-5 year target (April 2023)

Playtech - Bid at 680p; gain 127% (November 2021)

Playtech (October 2021)

Playtech (February 2021)

Playtech (September 2020)

Playtech - Q1 20 was best quarter on record (August 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X